Human CD5 / CD20 Antibody from EXALPHA BIOLOGICALS, INC.
Search, find, compare suppliers for anti-Human CD5 / CD20 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD5 / CD20 |
| Clone | monoclonal |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2a (F)/IgG1 (PE) |
| Format | FITC/PE conjugate, 2-color reagent |
| Size | 100 Tests |
| Concentration | Titered for flow cytometry |
| Applications | Flow Cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Mouse anti Human CD5 FITC - CD20 PE |
| Immunogen | CD5=Derived from the hybridization of mouse NS-1/Ag4 myeloma cells with spleen cells of BALB/c mice immunized with human t-acute lymphoblastic leukemia (ALL) cells. CD20=Derived from the hybridization of mouse Sp2/0 myeloma cells with spleen cells from BALB/c mice immunized with the LB lymphoblastoid cell line. |
| Other Names | CD5 FITC - CD20 PE |
| Gene, Accession # | UniProt: P06127, P11836 |
| Catalog # | 520 |
| Price | $374 |
| Order / More Info | Human CD5 / CD20 Antibody from EXALPHA BIOLOGICALS, INC. |
| Product Specific References | 1. Anti-DNA Antibody Production by CD5+ and CD5- B Cells of Patients with Systemic Lupus Erythematosus. Suzuki N., Sakane T., Engleman EG, J. Clin. Invest. 1990 Ja;85(1):238-47. 2. Characteristics of CD11c+ CD5+ Chronic B cell Leukemias and the Identification of Novel Peripheral Blood B cell Subsets with Chronic Lymphoid Leukemia Immunophenotypes. Wormsley SB, Baird SM, Gadol N., Rai KR, Sobol RE, Blood 1990 July. 76(1):123-30. 3. Stimulation of CD5 Enhances Signal Transduction by the T cell Antigen Receptor. Imboden JB, June CH, McCutcheon MA, Ledbetter JA, J. Clin. Invest. 1990 Ja;85(1):130-4. 4. Surface Immunoglobulin Ligands and Cytokines Differentially Affect Proliferation and Antibody Production by Human CD5+ and CD5- B Lymphocytes. Nawata Y., Stall Am, Herzenberg LA, Eugui Em, Allison AC, Int. Immunol. 1990;2(7):603-14. 5. Evidence for Differential Responsiveness of Human CD5+ and CD5- B cell Subsets to T cell Independent Mitogens. Zupo S., Dono M., Azzoni L., Chiorazzi N., Ferrarini M., Eur. J. Immunol. 1991 Fe. 21(2):351-9. 6. In Vivo and In Vitro Expression of Myeloid Antigens on B-lineage Acute Lymphoblastic Leukemia Cells. Leukemia, 1991, Ja;5(1):19-25. Hara, J.; Kawa-Ha, K.; Yumura-Yagi, K.; Kurahashi, H.; Tawa, A.; Ishihara, S.; Inoue, M.; Murayama, N.; Okada, S. 7. Activation of Dense Human Tonsilar B Cells. Induction of C-Myc Gene Expression via Two Distinct Signal Transduction Pathways. Immunol., 1991, Feb;146(3):846-53. White, M. W.; McConnnell, F.; Shu, G.L.; Morris, D.R.; Clark, E.A. 8. Differential Effects of Low and High Concentrations of Interleukin 6 on Human B Cell. Eur J. Immunol. 1990 No. 20(11) :2389-93. Levy, Y.; Fermand, J.P; Broute, J.C. 9. Immunophenotypes in Classical B-cell Chronic Lymphocytic Leukemia. Correlation with Normal Cellular Counterpart and Clinical Findings. Cancer, 1990, Oct. 1;66(8):1738-42. Baldini, L.; Cro, L.; Cortelezzi, A.; Calori, R.; Nobili, L.; Maiolo, A.T.; Polli, E. E. |
EXALPHA BIOLOGICALS, INC.
EXALPHA BIOLOGICALS, INC.
2 Shaker Road, Unit B101
Shirley MA 01464
P: 978-425-1370
info@exalpha.com
https://www.exalpha.com
Profile of EXALPHA BIOLOGICALS, INC.
Return to Antibodies